Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	39,067	22,555	32,012	35,749	76,786	35,439
Market Cap Growth	80.71%	-29.54%	-10.45%	-53.44%	116.67%	-
Enterprise Value	33,957	22,818	31,823	33,878	71,142	29,114
Last Close Price	54.21	38.48	54.26	60.32	128.99	59.08
PE Ratio	59.07	46.13	87.34	64.61	129.11	77.43
Forward PE	59.57	29.61	46.74	89.61	89.61	56.23
PS Ratio	11.88	7.63	15.14	14.65	32.49	23.67
PB Ratio	1.84	1.49	2.17	2.38	5.23	3.09
P/TBV Ratio	2.31	2.08	3.06	3.52	7.77	3.49
P/OCF Ratio	93.46	27.48	56.22	44.48	132.69	68.82
EV/Sales Ratio	10.33	7.71	15.05	13.88	30.10	19.45
EV/EBITDA Ratio	40.57	33.56	70.52	50.43	106.53	51.48
EV/EBIT Ratio	68.12	62.70	192.23	83.32	142.50	65.10
Debt / Equity Ratio	0.01	0.13	0.12	0.08	0.05	-
Debt / EBITDA Ratio	0.33	2.79	3.94	1.68	1.11	-
Asset Turnover	0.16	0.16	0.12	0.14	0.17	0.17
Inventory Turnover	1.78	1.60	1.01	1.17	1.56	1.01
Quick Ratio	5.86	1.99	1.70	4.75	8.14	16.89
Current Ratio	6.94	2.53	2.22	5.95	9.36	19.42
Return on Equity (ROE)	3.09%	3.18%	2.74%	4.12%	4.84%	5.67%
Return on Assets (ROA)	1.52%	1.20%	0.56%	1.49%	2.20%	3.08%
Return on Invested Capital (ROIC)	3.52%	2.76%	1.43%	4.57%	7.95%	9.62%
Return on Capital Employed (ROCE)	2.30%	2.30%	1.10%	2.50%	3.30%	3.80%
Earnings Yield	1.52%	2.17%	1.15%	1.55%	0.78%	1.29%
FCF Yield	-0.84%	-0.10%	-3.13%	-9.50%	-1.15%	-0.70%
Dividend Yield	0.74%	1.04%	0.35%	0.30%	0.25%	0.97%
Payout Ratio	53.00%	28.80%	37.58%	37.39%	57.11%	0.85%
Buyback Yield / Dilution	-10.81%	-0.05%	0.10%	0.11%	-7.38%	-6.91%
Total Shareholder Return	-10.07%	0.99%	0.45%	0.41%	-7.13%	-5.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.